Excited to share our results from the first RCT on dd-cfDNA after KTx! dd-cfDNA-guided intervention significantly reduced time to AMR-diagnosis compared to clinician-guided biopsy in dnDSA+KTR.
Big thanks to all that contributed to this daring project!🏅Now online on @NDTsocial
#Migräne betrifft Frauen dreimal häufiger als Männer. Dr. Bianca Raffaelli untersucht, ob die Blockade von Oxytocin Migräneattacken auslösen kann. Die Ergebnisse könnten zu neuen Therapien führen. 💡 @ChariteBerlin@Raffaelli_B
https://t.co/DGZt0yTOSd
🚀New data on how #TTVL reflect differences in intensity🌈of #immunosuppression and the impact of different induction agents on peak viral loads🦠. Very proud of my MD student Marvin Reineke, first author of this publication🙉: https://t.co/N4l5muBWEd @FrontImmunol@FrontPartners
Awaited data on CD38 inhibition for our ABMR patients. Felzartamab resulted in lower donor-derived cell-free DNA levels. Congrats to Georg Böhmig/Vienna team, and also the Berlin-team!
https://t.co/n15djseHnk